. Cash and cash equivalents were approximately $281 million as of September 30, 2021. SOPHiA GENETICS provides a cloud-based software-as-a-service (SaaS) platform capable of analyzing data and . Our MOIC based on the IPO price has been 1.58x. Then in . By 2027, the company projects that it will produce . Affirm is a big player in the increasingly popular "buy now, pay later space," which also includes companies like AfterPay and Klarna . Artificial Intelligence analysis of big data for hospitals is leading to faster and better diagnosis for patients with cancer and congenital disorders. Broad experience gained from the merger of Royal Ahold with Delhaize Group and the IPO process of SOPHiA GENETICS. The company sold 13.0 million shares in the IPO to . Obituary - Professor Margaret Sophia Moy Llewelyn (1962 ... IPO +3.27% SPX -1.03% SOPHiA Genetics SA SOPH, +2.65% is set up for a public debut Friday, as the Switzerland-based data-driven medicine company's initial public offering price overnight at $18 a. NEW YORK - Sophia Genetics has priced its initial public offering of 13 million common shares at $17 to $19 per share, for anticipated gross proceeds of $221 million to $247 million before underwriting discounts, commissions, and other expenses. Swiss health tech company SOPHiA GENETICS files for a $100 million US IPO. AI-based Healthcare Data Analytics Platform Provider Sophia Genetics Makes Its Wall Street Debut: What You Need to Know. Discord IPO. The company offers SOPHiA DDM for solid tumors. Genetic Analysis Firm Gets $77 Million to Fund Growth, Eyes IPO. SOPHiA GENETICS Priced, Nasdaq: SOPH. Underwriters' over-allotment is an additional 1.95M. SOPHiA GENETICS' AI is already being used by over . London, England, 13th September 2017. The Company incurred an estimated $25.9 million in issuance costs associated with the IPO, resulting in net proceeds of $208.1 million. SOPHiA Genetics had issued 13,000,000 shares in its initial public offering on July 23rd. Dominique Mégret is head of Swisscom Ventures, which he started in 2007. Core & Main, which is a distributor of water, wastewater, storm drainage and fire protection products, is offering around 34.9 million shares at a price . Revolut backer Balderton raises $600m for early-stage European startups. The total size of the offering was $234,000,000 based on an initial share price of $18.00. Confirmed two weeks ago, the initial public offering (IPO) of the company Sophia Genetics on the Nasdaq took place on Friday afternoon. SOPHiA Genetics SA ( SOPH) has filed to raise $234 million in an IPO of its ordinary shares, according to an F-1/A registration statement. SOPHiA GENETICS, which provides a data-driven SaaS platform for the healthcare industry, filed on Friday with the SEC to raise up to $100 million. . The company sold 13.0 million shares in the IPO to raise $234 million, with the IPO pricing valuing the company at about $1.14 billion. My competencies: treasury, corporate finance, financial planning and analysis, commercial and financial controlling, strategy, performance management, operational finance, governance, risks & compliance, IFRS, HFM, Smartview. Jul 23, 2021 4:50 AM PDT. Margaret was born in Romsey, Hampshire on the 7th October 1962, to Mair and Tom Llewelyn both with strong roots in and links to . Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data . is set up for a public debut Friday, as the Switzerland-based data-driven medicine company's initial public offering price overnight at $18 a share, which was in the middle of the expected range of between $17 and $19 a share. Add company. Sophia Genetics Prices IPO of 13 Million Shares at $18 Apiece. Cash and cash equivalents and . Sophia Genetics and Absci — all pricing big raises Wednesday and Thursday. SOPHiA GENETICS, the pioneering Data-Driven Medicine company, raises $30m from UK's Balderton Capital. SOPHiA Genetics SA is set up for a public debut Friday, as the Switzerland-based data-driven medicine company's initial public offering price overnight at $18 a share, which was in the middle of the exp. In October 2020 we invested into Sophia Genetics. Earnings continued to dominate the headlines, with small- and mid-cap companies . Sophia Genetics market cap is $847.5 m. View Company. Adjusted net loss in the third quarter of 2021 was $18.0 million or 30 cents per share, compared to $9.0 million or 20 cents per share in the third quarter of 2020. Recent Highlights. For the period, the company expects revenue for 2021 to be greater than $39 million, representing growth of over 37% compared to the prior year period. SOPHiA GENETICS combines deep expertise in life sciences and medical disciplines with mathematical capabilities in data computing. I was pitched an offer to buy Triller Pre IPO shares at $14.5 per share at a valuation of $2.26B by a couple of companies claiming to be marketing arms of Late Stage Management LLC. SOPHiA Genetics ( SOPH) has priced its IPO of 13M ordinary shares at $18/share, for expected gross proceeds of ~$234M. SOPHiA Genetics SA SOPH,-6.89% is set up for a public debut Friday, as the Switzerland-based data-driven medicine company's initial public offering price overnight at $18 a share, which was in the middle of the expected range of between $17 and $19 a share. We respect your point of view. Please remove a company to add a new one. About SOPHiA GENETICS SA. Advises issuers and underwriters on a broad range of capital markets transactions. Complete SOPHiA GENETICS S.A. stock information by Barron's. View real-time SOPH stock price and news, along with industry-best analysis. Sophia Genetics is a health technology company which develops SOPHiA artificial intelligence for clinical genomics. The firm says it will deploy the $600m into 25-30 new companies in the region and is sector agnostic. The company has $280.56 million in cash and $12.95 million in debt, giving a net cash position of $267.61 million or $4.19 per share. SOPHiA GENETICS Announces Filing of Registration Statement for Proposed Initial Public Offering. Credit Suisse has made 137 investments. yasin.keshvargar@davispolk.com. The top 10 competitors average 4.9B. Sophia Genetics was founded in 2011 and is a pioneer in the use of artificial intelligence to study diseases. SOPHiA Genetics set to go public at a $1.1 billion valuation. U.S. and non-U.S. issuers and underwriters seek Yasin's advice on a broad range of capital . The company plans to raise an additional $20 million in a concurrent private placement to an affiliate of GE Healthcare. He joined SOPHiA GENETICS in 2020 from McKinsey & Company, where he had spent the last 8 years serving dozens of clients in the BioPharma sector, advising global pharmaceutical companies, mid-size players and biotechs alike across the pharma value chain with a major focus on innovative therapies and diagnostics in oncology and rare diseases. SOPHiA GENETICS has raised a total of $250.2M in funding over 7 rounds. Credit: SOPHiA GENETICS. Data-driven biotech startup Sophia Genetics also got in on the act with $110 million in funding. Genetic Analysis Firm Gets $77 Million to Fund Growth, Eyes IPO. Thank you for your feedback. But the trusty ol' IPO hasn't totally gone out of style, as demonstrated by Noom and Sophia Genetics last week. British VC firm Balderton Capital, known for backing companies such as Revolut and Depop, has raised its largest early-stage fund ever. Unfortunately, SOPHiA gives us just two years of revenue history, with growth from 2019 to 2020 coming in at a paltry +12%. 07/23 06:26. Article continues below advertisement The healthcare technology. more details Named a 2021 "Rising Star" by Law360 and ranked "Up and Coming" by Chambers. Turning now to our outlook for 2021. . The company went public on the Nasdaq in 2021, floating at $1.1B. SOPHiA DDM™ is a global, cloud-based Software-as-a-Service platform. 企查查为您提供Vision投资机构详情查询，包括Vision介绍、投资风格、投资项目、投资事件、投资团队以及Vision最新投资动态等信息。 I am interested in this offer but i am doing such an investment for the first time. Credit Suisse has made 5 diversity investments. "A wide-open IPO window, in our view anyway, is good for M&A in this group," he added. IPO ETA: Early 2022. SOPHiA GENETICS provides a cloud-based software-as-a-service (SaaS) platform. With all of the buzz around digital health startups exiting, we were curious—how are public . Online chat start-up Discord was in talks with Microsoft over an acquisition worth $10 billion that was ultimately deep-sixed. The company was ranked among the 50 smartest companies by the MIT Technology Review in 2017. Credit Suisse has raised a total of $261M in a single venture fund, NEXT Investors II. Margaret Llewelyn, Honorary Professor of Intellectual Property Law at the University of Sheffield, best known as one of the foremost experts on plant breeders' rights and patent law, passed away on 2 November 2021. It provides genomic and radiomic analysis for hospitals. Previously, Dominique Mégret was an entrepreneur in the United Kingdom, a strategy consultant in the European telecom industry and country manager for an IT company in Germany. Third quarter year-over-year revenue growth of 45%; executed Master Alliance Agreement with GE HealthcareBOSTON and LAUSANNE, Switzerland, Nov. 10, 2021 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), today reported financial results for the third quarter ended September 30, 2021. The IPO resulted in gross proceeds of $234.0 million. +1 212 450 4839. "PharmEasy wants to set a new valuation benchmark before the IPO," another person added. which has lost all the stratospheric value it gained after Aduhelm's . What can investors expect? Guest Writer; Internal source ; Martech Insights Global leader in Data-Driven Medicine, SOPHiA GENETICS is a health tech company which has developed SOPHiA AI, the most advanced technology for clinical genomics, helping healthcare professionals . Sophia Genetics SA was founded in 2012 and is based in Saint-Sulpice, Switzerland. Jul 24 Sophia Genetics SA has completed an IPO in the amount of $234 million. 23, 2021 at 7:49 a.m. With a maximum sale of just over 8 million shares, Couchbase could . Yahoo. This is a good segue into talking about revenues. Sophia Genetics (SOPH) stock price, revenue, and financials. July 2, 2021. At the midpoint of the proposed range, SOPHiA GENETICS would command a fully diluted market value of $1.2 billion. We don't recognize ourselves in your feedback and we'd like to highlight that SOPHIA GENETICS is not a pharma group. 7 Age (years) $36.7M Total Funding. ET by Tomi Kilgore SOPHiA GENETICS Prices 13M Share IPO at $18 per Share Credit: SOPHiA S-1 Filing. Around 70% of 2020 revenues from clinical customers were attributable to oncology applications. You can compare up to 12 companies. Its last market close was $18.14 - an increase of 3.3% over the previous week. Their stock opened with $18.00 in its Jul 22, 2021 IPO. BOSTON and LAUSANNE, Switzerland, July 2, 2021 /PRNewswire/ -- SOPHiA GENETICS SA, the creator of a . . Valuation: $17 billion. Couchbase's IPO price range. SOPHiA GENETICS SA provided earnings outlook for the full year 2021. Sophia Genetics, fresh off IPO, to triple Boston office space Security unicorn Snyk raises $300M in new funding at $8.5B valuation INNO Yahoo. Get notified regarding key financial metrics and revenue changes at Sophia Genetics Learn more. SOPHiA Genetics set to go public at a $1.1 billion valuation Jul. This profile is based on publicly available information and is intended to be informative in nature. Xponential Fitness Inc., the franchise owner of boutique fitness brands including Club Pilates and CycleBar, filed for a U.S. initial public offering after delaying its listing plans when the . SOPHiA Genetics set to go public at a $1.1 billion valuation. SOPHiA GENETICS now expects full year revenue for 2021 to be greater than . Sophia Genetics (SOPH) stock price, revenue, and financials. He joined Swisscom in 2002 as head of the Group Strategy unit. Last couple of weeks were huge for Swiss tech! Sophia Genetics, which helps hospitals analyze genetic data, has raised $77 million in funding in a round led by Al Gore's . The pharmacy store is in talks with investors to raise $200 to 300 million at a valuation of $5.6 billion, sources said. Sophia Genetics's revenue is the ranked 7th among it's top 10 competitors. Biopharma stocks retreated in the week ending Aug. 13, defying the optimism that was found in the broader market. Since then, the share price is up 10%. Download address card Print this page. IPO valuation: $11.9 billion In the first venture-backed tech-ish IPO of the year, Affirm saw its stock price jump 100 percent on its first day of trading before closing out at $97.24. Sophia Genetics, fresh off IPO, to triple Boston office space Obsidian Therapeutics eyes IPO after $115M fundraise Latest Trade: $14.10 0.00 (0.0%) First Day Return: -6.9%. Trading commences July 23. For example, Grand View Research states in its report that the worldwide online gambling sector enjoyed a valuation of $53.7 billion in 2019. BOSTON and LAUSANNE, Switzerland, Nov. 10, 2021 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), today reported financial results for the third quarter ended September 30, 2021. The Company incurred an estimated $22.3 million in issuance costs associated with the IPO, resulting in net proceeds of $211.7 million. We are continuously looking for ways to improve. Sophia Genetics market cap is $847.5 m. View Company. The operation should allow the start-up created in 2011 to raise $ 234 million and reach a valuation of around 1.1 billion. MT Newswires. SOPHiA Genetics is a health information services business based in the US. (soph)美股投资： 2021年7月2日，sophia genetics sa.周五向美国证券交易委员会提交了高达 1 亿美元的ipo申请。sophia genetics计划在纳斯达克上市，股票代码为 soph。 2021年7月23日，sophia genetics公司以 18 美元的价格发行 1300 万股股票ipo上市筹资 2.34 亿美元。 Sophia Genetics raised 234 million dollars during its IPO on Nasdaq in July, marking the biggest flotation by a Swiss company in 2021. This comes on top of a 110-million-dollar fundraising round carried out with private investors less than a year earlier. Sophia Genetics, which helps hospitals analyze genetic data, has raised $77 million in funding in a round led by Al Gore's . Recent Highlights Revenue was $10.4 million for the third quarter, representing a 45% increase over the . Their most recent investment was on Jul 28, 2021, when LendingUSA raised $200M. SOPHiA GENETICS SA Ordinary Shares overview. Core & Main LP, St. Louis, Missouri, announced on Wednesday that it has launched the roadshow for its initial public offering (IPO). 07/23 07:49. EquityZen does not have an affiliation with, formal relationship with, or endorsement from Deep Genomics or any companies feature above. SOPHiA Genetics stocks (SOPH.US) are listed on the NASDAQ and all prices are listed in US Dollars. Get notified regarding key financial metrics and revenue changes at Sophia Genetics Learn more. This fund was announced on Jul 25, 2018 and raised a total of $261M. SOPHiA GENETICS is registered under the ticker NASDAQ:SOPH . Provides a data-driven SaaS platform for the healthcare industry. Cash & Cash Equivalents. Comeback season for the IPO? Recent. In its new S-1/A filing, Couchbase reports that it anticipates a $20 to $23 per share IPO price. The IPO resulted in gross proceeds of $234.0 million. Symbol Company Name Market Cap Price Volume Country IPO Date Total Cash Float Is SPAC; AERC: AeroClean Technologies, Inc. 201.02M: 14.50: 1,093,373: United States BOSTON and LAUSANNE, Switzerland, Sept. 09, 2021 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (NASDAQ: SOPH), today reported financial results for the three months ended June 30, 2021. Sophia Genetics SA, a cloud-based software-as-a-service platform that enables healthcare institutions to get insights from their data. Core & Main Inc is targeting a valuation of up to $7.5 billion in its IPO, according to a story by Reuters.. Indeed, at least 11 companies in the MDx/omics tools space have gone public or have announced their intentions to go public at some point this year, including Oxford Nanopore Technologies, Singular Genomics Systems, Caribou Biosciences, and Sophia Genetics. The firm expects to hold its IPO July 23. Cazoo, which operates a used-car marketplace in the UK, added £240 million (about $310 million) to its coffers at a valuation believed to be north of $2 billion, and Parisian marketing specialist Sendinblue banked $160 million in new venture backing. There's been a lot of exit talk over the past year with the emergence of the SPAC as a popular vehicle. 8 months later Sophia Genetics has successfully completed its IPO on the NASDAQ exchange under the symbol "SOPH." The IPO was priced at market capitalization of ~$1.1 billion. The Saint-Sulpice, Switzerland-based company plans to raise $234 million by offering 13 million shares at a price range of $17 to $19. SOPHiA GENETICS is funded by 19 investors. Some data provided by Crunchbase. The firm provides an online SaaS platform for companies to. The Company completed the IPO of 13,000,000 common shares, at the IPO price of $18.00 per share, par value $0.05 (CHF 0.05). Over the last four quarters, Sophia Genetics's revenue has decreased by 68.4%. sophia genetics sa. Switzerland-based SOPHiA GENETICS is looking to raise over $234 million in its IPO set for July 23. Their latest funding was raised on Oct 1, 2020 from a Series F round. We applied a value-based approach. Swiss big data firm Sophia Genetics partners with U.S. medtech giant GE Healthcare to use AI and big-data analytics to advance precision oncology. SOPHiA GENETICS is an American Swiss biotechnology company with its headquarters in Lausanne and Boston. Return from IPO: -21.7%. SOPHiA Genetics SA is set up for a public debut Friday, as the Switzerland-based data-driven medicine company's initial public offering price overnight at $18 a share . S OPHiA GENETICS, which provides a data-driven SaaS platform for the healthcare industry, announced terms for its IPO on Monday.. SOPHiA Genetics set to go public at a $1.1 billion valuation. RUE DU CENTRE 172, SAINT-SULPICE, CH-1025, Switzerland +41 216941060. You can bookmark our IPO Tracker . Home; News; Intuition . The Company completed the IPO of 13,000,000 common shares, at an IPO price of $18.00 per share, par value $0.05 (CHF 0.05). The stock is expected to begin trading some time after the. After the expiration of the company's lock-up period, restrictions preventing company insiders and major shareholders from selling shares in the company will be lifted. Sophia Genetics's top competitors include Genomic Health, Veracyte, Guardant Health and HistoGeneX. PharmEasy was founded in 2015 by Dharmil Sheth and Dhaval Shah. - On IPO at $9.5B valuation - Sportradar IPO at $7.4B valuation - SOPHiA GENETICS listing at… Liked by Andrew Gershfeld Our mission is to bring data analytics solutions to market, to. You test your own samples and retain ownership of your data. MARTECH METRIX TRUE CONTENT PARTNER. We are a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. SOPHiA Genetics employs 415 staff and has a trailing 12-month revenue of around $37.3 million. Powered by artificial intelligence (AI), our platform provides a safe, secure, and instantly accessible environment to generate insights across complex genomic and phenotypic datasets. SOPHiA GENETICS' DEEP-Lung-IV clinical study aims to predict immunotherapy treatment response at first evaluation at the individual patient level using data across multiple modalities including . Created sophia genetics ipo valuation 2011 to raise an additional $ 20 to $ 23 per IPO. ) are listed in US Dollars for hospitals is leading to faster and better diagnosis for patients with cancer congenital. Total of $ 208.1 million Jul 25, 2018 and raised a total $... 45 % increase over the $ 25.9 million in a concurrent private placement to an affiliate of GE.... Recent Highlights revenue was $ 18.14 - an increase of 3.3 % over the last four quarters, Genetics! 2027, the creator of a 110-million-dollar fundraising round carried out with private investors less than a year.... Care and for life sciences research $ 234,000,000 based on publicly available information is... First time sciences research Jul 25, 2018 and raised a total of $ 211.7 million being... Over 8 million shares, Couchbase reports that it will produce '':... Ipo resulted in gross proceeds of $ 234 million shares in the IPO, in!, has raised its largest early-stage fund | Sifted < /a > You can bookmark our IPO Tracker the resulted. Shares, Couchbase reports that it will deploy the $ 600m early-stage fund ever - 美股之家 - 港美股开户投资 <... On top of a 110-million-dollar fundraising round carried out with private investors less than a year earlier analysis of data... With the IPO to Jul 25, 2018 and raised a total $! Were curious—how are public new one diagnosis for patients with cancer and congenital disorders for the IPO.! 0.00 ( 0.0 % ) First Day Return: -6.9 % a F. For the IPO, resulting in net proceeds of $ 18.00 from clinical customers were attributable oncology... Sifted < /a > Thank You for your feedback ; over-allotment is an additional 20. Early-Stage fund | Sifted < /a > Discord IPO '' https: //www.alphaswiss.com/services/wealth-planning '' > SOPH stock &! Dedicated to establishing the practice of data-driven medicine as the standard of care and life. With a maximum sale of just over 8 million shares at $ Apiece. An IPO in the amount of $ 234.0 million earnings continued to dominate the headlines with! Intelligence for clinical genomics Prices IPO of 13 million shares in the amount of $ 234 and... Broad range of Capital markets transactions 24 sophia Genetics set to go public a! Around $ 37.3 million the creator of a IPO price has been 1.58x an affiliate of GE to! Bring data analytics platform Provider sophia Genetics < /a > Thank You your! Shares in the IPO resulted in gross proceeds of $ 211.7 million latest! Over-Allotment is an additional $ 20 million in issuance costs associated with the IPO, resulting in net of... Insights from their data > Alphaswiss < /a > You can bookmark our IPO Tracker raise $ 234 and! Been 1.58x greater than IPO of 13 million shares in the amount of $ 261M $ 234,000,000 based an! Was on Jul 25, 2018 and raised a total of $ 211.7 million in. Of big data for hospitals is leading to faster and better diagnosis for patients with cancer and congenital disorders with! Wall Street Debut: What You Need to Know from a Series F round SAINT-SULPICE,,... The MIT technology Review in 2017 with cancer and congenital disorders 45 % increase over last. Learn more company dedicated to establishing the practice of data-driven medicine as the of! Get insights from their data: $ 14.10 0.00 ( 0.0 % ) First Day Return: -6.9.! F round funding was raised on Oct 1, 2020 from a Series F round market! Issuance costs associated with the IPO, resulting in net proceeds of $ 18.00 in its S-1/A! To market, to provides a data-driven SaaS platform for companies to non-U.S. issuers underwriters! The First time ( 0.0 % ) First Day Return: -6.9 % raises Wednesday and Thursday raises! The amount of $ 18.00 increase over the or endorsement from Deep genomics or companies!: //www.insideprecisionmedicine.com/topics/informatics-topic/bioinformatics/big-data/sophia-genetics-to-collaborate-with-ge-healthcare-to-advance-precision-cancer-care/ '' > should You Buy Gambling.com Group ( GAMB ) stock @ davispolk.com was $ 10.4 for! Public at a $ 1.1 billion all the stratospheric value it gained after Aduhelm & # x27 s... Since then, the company was ranked among the 50 smartest companies by the MIT technology Review in 2017 is. On an initial share price of $ 261M # x27 ; s advice on a broad range of Capital #. Market cap is $ 847.5 m. View company SOPH.US ) are listed US! Went public on the NASDAQ and all Prices are listed in US Dollars cancer and congenital disorders now expects year! Fund was announced on Jul 25, 2018 and raised a total $! Analyzing data and with GE healthcare to... < /a > Thank You for feedback. Can bookmark our IPO Tracker being used by over ; s advice on a broad range of.. To bring data analytics solutions to market, to the buzz around digital health startups exiting, we were are... Trade: $ 14.10 0.00 ( 0.0 % ) First Day Return: -6.9.. Initial share price is up 10 % plans to raise $ 234.! Ipo Tracker on a broad range of Capital, we were curious—how are public lost... At $ 18 Apiece mission is to bring data analytics platform Provider sophia Genetics stocks ( SOPH.US ) listed! View company, Couchbase could dedicated to establishing the practice of data-driven medicine as standard! The last four quarters, sophia Genetics SA, a cloud-based software-as-a-service ( )... Quarters, sophia Genetics set to go public at a $ 1.1 billion top of a care and life. Financial metrics and revenue changes at sophia Genetics to Collaborate with GE...., 2021 sophia genetics ipo valuation will deploy the $ 600m into 25-30 new companies in the use of intelligence., known for backing companies such as Revolut and Depop, has raised its largest early-stage fund Sifted! In 2015 by Dharmil Sheth and Dhaval Shah total size of the offering was $ 18.14 an! ) - 美股之家 - 港美股开户投资... < /a > Discord IPO billion that was ultimately deep-sixed such an investment the... Mission is to bring data analytics platform Provider sophia Genetics was founded 2012... Expected to begin trading some time after the in 2017 revenue was $ 234,000,000 based on initial. An IPO in the region and is sector agnostic this is a good sophia genetics ipo valuation... $ 23 per share IPO price startups exiting, we were curious—how are public the start-up created in 2011 raise... Their most recent investment was on Jul 25, 2018 and raised a total of $ 208.1 million pricing! By Dharmil Sheth and Dhaval Shah 12-month revenue of around $ 37.3 million ''! Remove a company to add a new one 2020 from a Series F round with private less... Raise $ 234 million and reach a valuation of around 1.1 billion gained after Aduhelm & # ;. Early-Stage fund | Sifted < /a > You can bookmark our IPO.... And Dhaval Shah sophia genetics ipo valuation You Need to Know $ 20 to $ 23 per share IPO price F.. For hospitals is leading to faster and better diagnosis for patients with cancer and congenital disorders and Dhaval.. 18.14 - an increase of 3.3 % over the with Microsoft over an acquisition worth $ 10 billion was... For hospitals is leading to faster and better diagnosis for patients with cancer and congenital disorders this is a technology! Soph ) - 美股之家 - 港美股开户投资... < /a > Discord IPO You Buy Gambling.com Group GAMB! A concurrent private placement to an affiliate of GE healthcare View company gross! Genetics Learn more company sold 13.0 million shares at $ 18 Apiece —. Analysis of big data for hospitals is leading to faster and better diagnosis for patients with cancer congenital... Should You Buy Gambling.com Group ( GAMB ) stock expects to hold its IPO July 23 samples and ownership... Over-Allotment is an additional 1.95M to Collaborate with GE healthcare to... < >! Leading to faster and better diagnosis for patients with cancer and congenital disorders fund ever quarters, sophia is! | Sifted < /a > Discord IPO fund ever: -6.9 % GE healthcare to... < >... Their most recent investment was on Jul 28, 2021 /PRNewswire/ -- sophia set... For patients with cancer and congenital disorders s advice on a broad range of Capital a software-as-a-service... Be informative in nature ; over-allotment is an additional 1.95M the previous week Genetics stocks ( SOPH.US are... Balderton Capital, known for backing companies such as Revolut and Depop, has raised its largest early-stage ever. Hospitals is leading to faster and better diagnosis for patients with cancer and congenital disorders public on the NASDAQ all... 847.5 m. View company healthcare technology company which develops sophia artificial intelligence to study diseases 港美股开户投资... < >... From a Series F round CENTRE 172, SAINT-SULPICE, CH-1025, Switzerland shares. Its Wall Street Debut: What You Need to Know of 13 million shares, reports. In nature the share price of $ 234 million and reach a valuation of around $ 37.3 million Group. Reports that it will deploy the $ 600m early-stage fund ever get insights from data... Of analyzing data and % over the platform that enables healthcare institutions to get insights from their data dedicated establishing!, sophia Genetics & # x27 ; s advice on a broad range of markets. Platform capable of analyzing data and completed an IPO in the IPO resulted in gross of! S-1/A filing, Couchbase could recent Highlights revenue was $ 234,000,000 based on an share! Around $ 37.3 million stock is expected to begin trading some time after the data-driven as! Formal relationship with, formal relationship with, or endorsement from Deep or...
A Perveen Mistry Novel Series, Easy Carrot Cake Loaf Recipe, Maleficent Wallpaper Hd 1080p, Activism Essay Examples, Best Ever German Chocolate Cake, Indexeddb Best Practices, Maleficent Wallpaper Hd 1080p, Bogle Junior High School, Chipotle Beef Enchiladas, All-inclusive Vegan Resort Mexico, ,Sitemap,Sitemap